Global Blood Therapeutics... (GBT)

68.49

0.01 (0.01%)

At close: Oct 04, 2022, 8:00 PM

Global Blood Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	-303.09M	-247.55M	-266.77M	-174.19M	-117.02M	-82.47M
Depreciation & Amortization	8.62M	10.82M	9.93M	4.61M	1.66M	1.24M
Stock-Based Compensation	78.67M	71.48M	45.65M	30.08M	13.68M	9.23M
Other Working Capital	-11.27M	-4M	26.5M	6.03M	5.19M	3.21M
Other Non-Cash Items	1.43M	658K	-10.31M	-616K	704K	n/a
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	-42.44M	-47.27M	27.08M	4.75M	7.96M	4.28M
Operating Cash Flow	-256.81M	-211.86M	-194.42M	-135.38M	-93.02M	-67.72M
Capital Expenditures	-3.23M	-8.75M	-3.46M	-4.82M	-3.1M	-1.35M
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	-50.35M	-57.94M	-434.92M	-361.4M	-127.72M	-105.5M
Sales Maturities Of Investments	65.7M	384M	361.47M	182M	96.01M	n/a
Other Investing Acitivies	n/a	n/a	45K	75K	-1.09M	n/a
Investing Cash Flow	12.11M	317.31M	-76.86M	-184.16M	-35.91M	-106.85M
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	-12K	-421K	-90K
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	434.33M	87.12M	298.16M	397.91M	235.19M	118.14M
Financial Cash Flow	434.33M	87.12M	298.16M	397.91M	235.19M	118.14M
Net Cash Flow	189.95M	192.57M	26.88M	78.37M	106.26M	-56.43M
Free Cash Flow	-260.05M	-220.62M	-197.88M	-140.2M	-96.12M	-69.08M